Lung Mass: What It Means, Causes, Diagnosis, and Treatment

A lung mass is an abnormal area of tissue in the lung that measures more than 3 centimeters, or about 1.2 inches, across. Finding one on a chest X-ray or CT scan can be concerning because larger lung lesions have a greater likelihood of being cancerous than smaller lung nodules.

However, a lung mass is not automatically cancer. Infections, inflammation, scar tissue, and benign tumors can sometimes create similar findings.

Determining the cause requires careful evaluation of the mass itself, the surrounding lung tissue, previous imaging, symptoms, medical history, and individual cancer risk.

What Is a Lung Mass?

A lung mass is an abnormal area within the lung that measures more than 3 centimeters in greatest dimension. Radiologists use size as one of the main features for distinguishing a pulmonary nodule from a pulmonary mass.

A pulmonary nodule is generally defined as a rounded opacity measuring less than 3 centimeters. Once a lesion exceeds 3 centimeters, it is usually classified as a mass.

The term “mass” describes what is seen on an imaging study. It does not describe the underlying disease and does not mean that cancer has been confirmed.

A lung mass may represent:

• Primary lung cancer
• Cancer that has spread to the lungs
• A bacterial or fungal infection
• A lung abscess
• Granulomatous disease
• An inflammatory or autoimmune condition
• A benign tumor
• Scar tissue
• Organizing pneumonia
• Rounded atelectasis
• Certain vascular or congenital abnormalities

Because a mass is larger than a typical lung nodule, it generally warrants more extensive evaluation rather than simple long-term observation without establishing its cause.

The location also matters. A mass can develop in any lobe of either lung. It may be located near the outer surface of the lung, deep within the lung tissue, or centrally near the major airways and blood vessels. Its location may influence symptoms, the suspected diagnosis, and the method used to obtain a biopsy.

Lung Mass vs. Lung Nodule

The main technical difference between a lung mass and a lung nodule is size. A lung nodule measures up to approximately 3 centimeters, while a lung mass measures more than 3 centimeters.

This distinction is important because the probability of malignancy generally increases as the size of a pulmonary lesion increases. A large lesion therefore receives greater attention during diagnostic evaluation. However, size does not provide a diagnosis.

A 4-centimeter mass may be caused by an infection, while a much smaller nodule may represent an early lung cancer. Healthcare providers must consider size together with imaging characteristics, growth, symptoms, age, smoking history, previous cancer, and other clinical information.

The management also tends to differ. Many very small nodules can be monitored with follow-up CT scans, depending on the patient’s risk and the appearance of the nodule. A true lung mass is more likely to require a diagnostic CT, PET/CT, specialist referral, tissue sampling, or another form of prompt evaluation.

What Causes a Lung Mass?

Many diseases can produce an abnormal area large enough to be described as a lung mass. Cancer is an important consideration, but it is not the only possibility.

Primary Lung Cancer

One of the most concerning causes of a lung mass is primary lung cancer, meaning cancer that begins in the lung itself.

The two major categories are:

• Non-small cell lung cancer
• Small cell lung cancer

Non-small cell lung cancer accounts for most primary lung cancers and includes several subtypes, such as adenocarcinoma and squamous cell carcinoma.

Adenocarcinoma often develops toward the outer portions of the lung. Squamous cell carcinoma has historically been associated more commonly with central airways, although either type can occur in different locations.

Small cell lung cancer often develops centrally and may be associated with enlarged lymph nodes in the chest. It tends to grow and spread more rapidly than most forms of non-small cell lung cancer.

When imaging suggests lung cancer, tissue is generally obtained so that a pathologist can identify the exact cancer type. The National Cancer Institute notes that biopsy is used when lung cancer is suspected because treatment depends heavily on the histologic diagnosis.

Cancer That Has Spread to the Lung

A lung mass may also represent cancer that began somewhere else in the body and spread to the lung. This is called pulmonary metastasis.

Many cancers can metastasize to the lungs, including cancers of the:

• Breast
• Colon and rectum
• Kidney
• Head and neck
• Thyroid
• Skin
• Bone
• Soft tissue

Metastatic cancer may produce one mass, several masses, or numerous smaller nodules. A history of cancer is therefore an important part of evaluating any new pulmonary abnormality.

However, a person who previously had cancer can still develop a completely unrelated benign lung lesion or a new primary lung cancer. Imaging alone may not reliably distinguish these possibilities.

Bacterial Infections

Certain bacterial infections can produce mass-like abnormalities. Pneumonia usually causes an area of consolidation rather than a discrete mass, but some infections can produce localized rounded opacities that resemble tumors.

An infection may be more likely when the abnormality appears rapidly and is associated with symptoms such as:

• Fever
• Chills
• Productive cough
• Fatigue
• Chest pain
• Elevated white blood cell count

Follow-up imaging after appropriate treatment may show that the abnormality has decreased or completely resolved.

However, clinicians must be cautious about assuming that a suspicious mass is pneumonia simply because the patient has respiratory symptoms. Lung cancer can obstruct an airway and cause pneumonia behind the obstruction, and the tumor may remain after the infection improves.

Lung Abscess

A lung abscess is an area of infected lung tissue that becomes filled with pus and damaged tissue. On CT imaging, an abscess may appear as a mass-like lesion with a cavity in the center.

Possible symptoms include:

• Fever
• Cough
• Foul-smelling sputum
• Chest discomfort
• Fatigue
• Night sweats
• Weight loss

Risk factors may include aspiration, poor dental health, impaired consciousness, swallowing disorders, and certain infections.

A lung abscess can occasionally resemble a cavitary lung cancer. The patient’s symptoms, laboratory findings, CT appearance, response to treatment, and sometimes biopsy help distinguish between them.

Fungal Infections

Fungal infections can also produce large pulmonary lesions.

Examples include:

• Histoplasmosis
• Blastomycosis
• Coccidioidomycosis
• Aspergillosis

Geographic location and exposure history are important because certain fungi are more common in particular regions. A fungal lesion may resemble lung cancer on CT, and some fungal infections can also produce increased activity on PET imaging.

This is an important limitation of PET/CT. Increased metabolic activity does not automatically mean cancer because infection and inflammation can also absorb the radioactive glucose-like tracer used during the study.

Tuberculosis

Tuberculosis can create nodules, masses, areas of consolidation, cavities, enlarged lymph nodes, or combinations of these findings. A localized tuberculous lesion may occasionally resemble a lung tumor.

Possible symptoms include persistent coughing, fever, night sweats, fatigue, coughing up blood, and unexplained weight loss. However, tuberculosis can sometimes be present with mild or nonspecific symptoms.

Note: Evaluation may include tuberculosis testing, sputum studies, bronchoscopy, cultures, and biopsy depending on the circumstances.

Inflammatory and Autoimmune Conditions

Several inflammatory diseases can form mass-like lesions within the lungs.

Examples include:

• Granulomatosis with polyangiitis
• Rheumatoid arthritis
• Sarcoidosis
• Organizing pneumonia
• Other autoimmune or inflammatory disorders

Granulomatosis with polyangiitis, for example, can produce pulmonary nodules and masses that may develop cavities. Rheumatoid arthritis can be associated with pulmonary rheumatoid nodules, particularly in certain patients with longstanding disease.

Sarcoidosis more commonly produces multiple nodules and enlarged lymph nodes, but its imaging appearance can vary considerably. Clinical history, laboratory testing, imaging patterns, and tissue sampling may be necessary to distinguish inflammatory disease from malignancy or infection.

Organizing Pneumonia

Organizing pneumonia is an inflammatory lung disorder in which granulation tissue develops within small airways and air spaces.

Although it frequently produces patchy areas of lung opacity, focal organizing pneumonia can sometimes present as a solitary mass and closely resemble lung cancer. The American Thoracic Society describes focal organizing pneumonia as a possible mass-like presentation that can simulate malignancy.

Patients may have coughing, shortness of breath, fever, fatigue, or other respiratory symptoms, although presentations vary. Biopsy may be necessary when imaging cannot distinguish organizing pneumonia from cancer.

Benign Lung Tumors

Not every lung tumor is cancerous. Pulmonary hamartoma is one of the better-known benign lung tumors. It contains an unusual mixture of tissues that normally occur in the lung, such as cartilage, fat, connective tissue, and smooth muscle.

Hamartomas are often small, but some can become large enough to qualify as masses. CT findings that may suggest a hamartoma include visible fat or certain characteristic patterns of calcification.

Other benign tumors can develop from nerve tissue, smooth muscle, connective tissue, or other structures. A benign tumor may still require biopsy or removal if it is enlarging, causing symptoms, obstructing an airway, or difficult to distinguish from cancer.

Scar Tissue

Previous lung injury can leave areas of fibrosis or scarring that occasionally appear mass-like.

Possible causes include:

• Previous infection
• Radiation therapy
• Surgery
• Trauma
• Chronic inflammation
• Occupational lung disease

Old imaging is particularly useful in this situation. A lesion that has remained unchanged for many years is generally more reassuring than a newly developed or enlarging mass.

However, clinicians still evaluate the overall appearance because cancer can sometimes develop in or near areas of abnormal lung tissue.

Rounded Atelectasis

Rounded atelectasis is a form of localized lung collapse that can mimic a tumor. It commonly occurs near an abnormal pleural surface and may be associated with pleural thickening or previous pleural disease.

CT can sometimes identify characteristic features suggesting rounded atelectasis, including blood vessels and airways curving toward the collapsed region. When imaging findings are not typical, additional evaluation may be necessary to exclude cancer.

Does a Lung Mass Mean Cancer?

No, a lung mass does not automatically mean that someone has lung cancer. The term describes the size and appearance of an abnormality, not its microscopic diagnosis.

However, a mass is more concerning for malignancy than a small pulmonary nodule. For that reason, healthcare providers typically investigate a lung mass promptly rather than assuming that it is harmless.

The estimated likelihood of cancer depends on several factors, including:

• Size
• Growth
• Shape
• Margins
• Density
• Location
• Presence of cavitation
• Lymph node enlargement
• Age
• Smoking history
• Previous cancer
• Occupational exposures
• Family history
• Symptoms

Note: A suspicious appearance raises the probability of malignancy but does not establish it. Likewise, an apparently smooth or well-defined mass cannot always be assumed to be benign. Ultimately, tissue examination is often required when cancer remains a significant possibility.

What Does a Lung Mass Look Like on Imaging?

A lung mass may first appear as a white or gray opacity on a chest X-ray. CT provides far more information and is usually necessary for detailed evaluation.

Size

Radiologists measure the lesion in millimeters or centimeters. If an abnormal pulmonary lesion exceeds 3 centimeters, it generally falls into the mass category rather than the nodule category.

Size is important because larger lesions have a greater average probability of malignancy. The dimensions can also be compared with earlier scans to determine whether the mass has grown.

Shape and Margins

A mass may be:

• Round
• Oval
• Lobulated
• Irregular

The edges may be smooth or poorly defined. Spiculated margins are particularly concerning. Spiculation refers to thin strands or projections extending from the mass into the surrounding lung.

Cancer can produce this appearance as tumor cells and fibrous tissue interact with surrounding structures. However, scarring and inflammation can occasionally create irregular or spiculated appearances as well.

Cavitation

Some masses contain a hollow or air-filled region known as a cavity.

Cavitary lung masses can occur with:

• Squamous cell lung cancer
• Bacterial infections
• Lung abscesses
• Tuberculosis
• Fungal infections
• Autoimmune disease
• Metastatic cancer

Note: The thickness and appearance of the cavity wall provide clues, but neither a thick wall nor a thin wall provides a definitive diagnosis by itself.

Calcification

Calcium within a pulmonary lesion can sometimes support a benign cause. Certain dense or characteristic calcification patterns may occur with old granulomatous infections or hamartomas.

However, the presence of calcium does not automatically exclude malignancy. Radiologists evaluate the location, distribution, and pattern of calcification together with the other characteristics of the mass.

Relationship to Airways

A centrally located tumor can grow within or around a bronchus.

Airway obstruction may lead to:

• Collapse of part of the lung
• Recurrent pneumonia
• Air trapping
• Mucus retention
• Cough
• Wheezing
• Shortness of breath

Note: Bronchoscopy can be particularly useful when a mass involves or lies close to a major airway.

Enlarged Lymph Nodes

Radiologists also evaluate the lymph nodes within the chest. Enlarged lymph nodes may result from infection, inflammation, lymphoma, lung cancer, or metastatic disease.

When lung cancer is suspected, lymph node evaluation becomes important for staging because treatment decisions depend partly on whether cancer has spread beyond the original tumor.

What Symptoms Can a Lung Mass Cause?

Some lung masses cause no symptoms and are discovered during imaging performed for another reason. Others produce symptoms because of their size, location, underlying cause, or effects on nearby structures.

Possible symptoms include:

• Persistent cough
• Change in a chronic cough
• Coughing up blood
• Shortness of breath
• Wheezing
• Chest pain
• Hoarseness
• Recurrent pneumonia
• Fever
• Fatigue
• Loss of appetite
• Unexplained weight loss
• Night sweats

The presence of these symptoms does not prove that a mass is cancerous. For example, fever and productive coughing may accompany infection, while inflammatory diseases may cause fatigue, fever, and other systemic symptoms.

Conversely, the absence of symptoms does not mean that a mass is benign. Early or localized lung cancer may produce few noticeable symptoms.

How Is a Lung Mass Found?

Chest X-Ray

A chest X-ray may be the first test to reveal a mass. Larger pulmonary abnormalities are generally easier to detect on X-ray than very small nodules, although the lungs contain many overlapping structures that can obscure or imitate disease.

The heart, ribs, blood vessels, diaphragm, and other tissues may overlap with the lungs on a standard chest X-ray. When a mass or suspicious opacity is identified, CT is typically needed to determine its exact location and characteristics.

Computed Tomography

CT is one of the most important imaging tests in the evaluation of a lung mass. CT produces detailed cross-sectional images of the chest and provides substantially more anatomical detail than a standard X-ray.

It can show:

• Exact size
• Shape
• Margins
• Density
• Calcification
• Cavitation
• Involvement of nearby structures
• Airway obstruction
• Enlarged lymph nodes
• Additional nodules or masses
• Pleural abnormalities
• Other areas of lung disease

Note: Intravenous contrast may be used when clinicians need additional information about blood vessels, lymph nodes, the mediastinum, chest wall involvement, or other structures. The exact CT protocol depends on what is being investigated.

What Happens After a Lung Mass Is Found?

The discovery of a lung mass usually begins a more focused diagnostic evaluation.

Review of Previous Imaging

Previous chest X-rays and CT scans can provide some of the most valuable information.

Clinicians want to know whether the mass is:

• New
• Growing
• Stable
• Shrinking
• Changing in density or appearance

A newly developed mass may require a different approach from an abnormality that has been visible and unchanged for many years.

Patients who have undergone imaging at another hospital or clinic should tell their healthcare provider where the studies were performed. Whenever possible, the actual images should be compared rather than relying only on old written reports.

Medical History and Risk Assessment

The clinician will review factors that may help identify the cause and estimate the likelihood of cancer.

These commonly include:

• Age
• Current smoking
• Previous smoking
• Total smoking exposure
• Previous cancer
• Family history of lung cancer
• Radon exposure
• Asbestos exposure
• Other occupational exposures
• Previous tuberculosis
• Fungal exposure
• Immune system problems
• Autoimmune disease
• Recent infection
• Symptoms
• Unexplained weight loss

Note: Smoking is an important risk factor, but lung cancer also occurs in people who have never smoked. The complete clinical picture matters more than any individual characteristic.

PET/CT Scan

PET/CT combines anatomical imaging with information about metabolic activity. Before the examination, the patient receives a small amount of a radioactive glucose-like substance. Areas that use larger amounts of glucose may accumulate more tracer and appear more metabolically active.

Many cancers have increased metabolic activity. However, PET/CT cannot independently diagnose lung cancer.

Infection and inflammation can also show increased activity and produce a false-positive result. Some slow-growing cancers can show relatively little activity and produce a false-negative result.

PET/CT can be particularly useful when evaluating a suspicious lung mass because it may help:

• Estimate how metabolically active the mass is
• Evaluate lymph nodes
• Look for possible spread elsewhere in the body
• Identify a useful location for biopsy
• Assist with cancer staging

Note: PET/CT is commonly incorporated into the evaluation of suspected lung cancer along with CT and tissue sampling.

Does a Lung Mass Need a Biopsy?

Many lung masses require tissue sampling, particularly when cancer cannot be reasonably excluded through imaging and clinical evaluation. A biopsy removes cells or tissue for examination by a pathologist.

The best biopsy method depends on:

• Mass location
• Mass size
• Relationship to an airway
• Nearby blood vessels
• Presence of enlarged lymph nodes
• Suspected diagnosis
• Lung function
• Other medical conditions
• Whether cancer staging is also needed

Note: A biopsy may occasionally be unnecessary if imaging and clinical findings clearly indicate another diagnosis or if surgical removal is already the most appropriate approach. The decision should be individualized.

Types of Lung Mass Biopsy

CT-Guided Needle Biopsy

CT-guided transthoracic needle biopsy involves passing a needle through the chest wall and into the abnormal lung tissue while CT imaging is used for guidance. It is often useful for peripheral masses located relatively close to the chest wall.

The procedure is generally less invasive than surgical biopsy and typically does not require general anesthesia.

Possible complications include:

• Pneumothorax
• Bleeding
• Coughing up blood
• Pain
• Infection

Pneumothorax occurs when air enters the space between the lung and chest wall, causing part of the lung to collapse.

A small pneumothorax may only require observation. A larger one may require placement of a chest tube to remove the air. A needle biopsy can occasionally be inconclusive if an adequate tissue sample cannot be obtained.

Bronchoscopy

Bronchoscopy uses a flexible tube containing a camera that is passed through the mouth or nose and into the airways. It is particularly useful for centrally located masses or lesions that communicate with a bronchus.

During bronchoscopy, the physician may obtain:

• Tissue biopsies
• Brushings
• Washings
• Fluid samples

Advanced techniques can help reach peripheral lung lesions that would previously have been difficult to access.

These include:

• Robotic bronchoscopy
• Electromagnetic navigation bronchoscopy
• Radial endobronchial ultrasound
• Fluoroscopy
• Cone-beam CT guidance

Note: The availability of these techniques varies between medical centers.

Endobronchial Ultrasound

Endobronchial ultrasound, or EBUS, combines bronchoscopy with ultrasound. It allows clinicians to visualize and sample lymph nodes and masses located next to the central airways.

EBUS may be especially helpful when lung cancer is suspected because lymph nodes can sometimes be sampled during the same procedure used to establish the diagnosis. This provides information about both the type of cancer and whether it has spread to particular lymph nodes.

Surgical Biopsy

Surgical biopsy may be appropriate when less invasive testing cannot establish a diagnosis or when a mass has such a high probability of cancer that surgical removal is appropriate. Video-assisted thoracic surgery and robotic thoracic surgery allow surgeons to enter the chest through relatively small incisions.

Depending on the circumstances, the surgeon may remove:

• A wedge of lung tissue
• A lung segment
• A lobe

Nearby lymph nodes may also be sampled. Surgical biopsy provides a larger amount of tissue than needle or bronchoscopic biopsy but also carries greater procedural risks.

Before surgery, clinicians evaluate lung function, heart health, functional status, and other medical conditions to determine whether the patient can safely tolerate the procedure.

What Can a Pathology Report Show?

Once tissue is obtained, a pathologist examines it under a microscope.

The biopsy may identify:

• Benign tissue
• Infection
• Granulomatous inflammation
• Organizing pneumonia
• Primary lung cancer
• Metastatic cancer
• Lymphoma
• Another disease

If cancer is present, pathology determines the tumor type. Additional laboratory studies may also evaluate proteins, genes, or other molecular characteristics within the tumor.

These results have become increasingly important because some lung cancers can be treated with medications directed at specific molecular abnormalities. Tumor testing may also help determine whether immunotherapy is likely to be useful.

Can Blood Tests Diagnose a Lung Mass?

Routine blood tests cannot determine with certainty whether a lung mass is cancerous. Blood testing can still provide useful information.

Depending on the suspected cause, clinicians may order:

• Complete blood count
• Kidney function tests
• Liver function tests
• Tests of inflammation
• Tuberculosis testing
• Fungal studies
• Autoimmune testing
• Tests needed before a procedure

If cancer has already been diagnosed, blood tests may also help evaluate general health and determine whether certain treatments can be given safely.

Blood-based tumor and molecular tests are increasingly used in cancer care, but they do not replace appropriate imaging, pathology, and clinical evaluation when a suspicious pulmonary mass is being diagnosed.

If a Lung Mass Is Cancer, What Happens Next?

Once cancer is diagnosed, clinicians determine how far it has spread. This process is called staging.

Staging may involve:

• CT scans
• PET/CT
• Brain MRI
• Bronchoscopy
• EBUS
• Lymph node biopsy
• Other procedures when necessary

The extent of the primary tumor, lymph node involvement, and spread to distant parts of the body all influence the stage.

Tumor size itself also contributes to lung cancer staging. Current staging systems divide tumors into different categories based partly on their dimensions and whether they have invaded nearby structures.

Accurate staging matters because a small localized cancer may be treated very differently from cancer that has spread to lymph nodes or distant organs.

How Is a Lung Mass Treated?

Treatment depends entirely on the underlying cause. A lung mass is an imaging finding and therefore does not have one universal treatment.

Benign Masses

A clearly benign mass may not require treatment. Observation may be appropriate when:

• Imaging strongly supports a benign diagnosis
• The lesion has remained stable
• Biopsy confirms a benign cause
• The mass is not producing symptoms

Note: Removal may still be considered if a benign tumor grows, blocks an airway, causes recurrent infections, produces bleeding, or remains difficult to distinguish from cancer.

Bacterial Infection

A bacterial infection is treated with appropriate antimicrobial therapy. The specific medication and duration depend on the organism, severity, location, and overall health of the patient.

Follow-up imaging is often important when a mass-like opacity was initially attributed to infection. The purpose is to verify that the abnormality resolves or substantially improves after treatment.

Note: An opacity that persists after pneumonia has otherwise improved may need additional evaluation.

Lung Abscess

A lung abscess generally requires prolonged antibiotic therapy directed toward the suspected organisms. Some patients may require drainage or another intervention if medical treatment is unsuccessful or complications develop.

Because cavitary lung cancer can resemble an abscess, persistent abnormalities may require bronchoscopy or biopsy.

Fungal Infection

Treatment varies considerably depending on the fungal organism. Some healed fungal lesions require no treatment.

Active or severe fungal disease may require antifungal medication, particularly in people with weakened immune systems. The diagnosis may involve fungal antigen testing, cultures, bronchoscopy, or biopsy.

Inflammatory Disease

If the mass is caused by an inflammatory or autoimmune condition, treatment focuses on the underlying disease. Corticosteroids or other immune-modifying medications may be appropriate for selected conditions.

However, clinicians generally need to consider infection carefully before suppressing the immune system because certain infections can closely resemble inflammatory lung disease.

Lung Cancer

Treatment for a cancerous lung mass depends on:

• Cancer type
• Stage
• Tumor location
• Lymph node involvement
• Molecular characteristics
• Lung function
• Overall health

Possible treatments include:

• Surgery
• Radiation therapy
• Chemotherapy
• Targeted therapy
• Immunotherapy
• A combination of treatments

For localized non-small cell lung cancer, surgery may offer the opportunity to completely remove the tumor. Surgery may involve removing a wedge, segment, or lobe of the affected lung. Lymph nodes are typically evaluated as part of cancer surgery when appropriate.

For patients who have an early-stage cancer but cannot safely undergo surgery, stereotactic body radiation therapy may be considered.

More advanced lung cancers often require systemic treatments such as chemotherapy, immunotherapy, targeted therapy, or combinations of these approaches. The treatment plan is based on the specific cancer rather than simply the dimensions of the mass.

Can a Lung Mass Be Removed?

Yes, some lung masses can be surgically removed. Whether surgery is appropriate depends on the diagnosis and the patient’s ability to tolerate an operation.

For suspected or confirmed lung cancer, surgeons consider whether the tumor can be completely removed and whether the cancer appears to have spread.

Preoperative testing may include:

• Pulmonary function tests
• Cardiac evaluation
• CT imaging
• PET/CT
• Lymph node evaluation
• Laboratory testing

The amount of lung removed depends on tumor size, location, and other clinical factors. Possible operations include wedge resection, segmentectomy, lobectomy, and, less commonly, removal of an entire lung.

Note: Not every patient with lung cancer requires surgery, and not every patient with an operable tumor is physically able to tolerate major lung resection.

Can a Lung Mass Shrink or Go Away?

Yes. Some noncancerous masses can become smaller or disappear.

This may occur when the abnormality is caused by:

• Pneumonia
• Lung abscess
• Fungal infection
• Inflammation
• Organizing pneumonia
• Temporary areas of lung collapse

A reduction in size after appropriate treatment is reassuring, but follow-up must be interpreted carefully. Some cancers can temporarily appear smaller because surrounding inflammation has improved, and some treatments can reduce the size of a malignant mass.

Therefore, improvement on one scan does not necessarily establish a benign diagnosis unless the clinical situation supports that conclusion.

Can a Benign Lung Mass Grow?

Yes, growth increases concern for cancer, but benign lesions can sometimes enlarge.

Possible reasons include:

• Active infection
• Increasing inflammation
• Enlargement of a benign tumor
• Changes within a cystic lesion
• Bleeding
• Progressive granulomatous disease

The rate and pattern of growth are important. A mass that grows substantially over a short period may suggest an aggressive infection or inflammatory process, although rapidly growing cancers are also possible.

Cancer growth rates vary considerably. Some tumors grow quickly, while others enlarge relatively slowly. A growing mass therefore requires further investigation rather than an assumption about the diagnosis.

What Does It Mean if a Lung Mass Is Stable?

A stable mass has shown no meaningful change between imaging studies. Long-term stability is generally reassuring, particularly when previous scans demonstrate that the lesion has remained unchanged for years.

However, the significance depends on the type of lesion and the quality and duration of the comparison.

Clinicians also consider:

• Density
• Margins
• Calcification
• Symptoms
• Cancer risk
• Whether the mass was accurately measured
• Whether the same imaging technique was used

Note: A mass that remains suspicious despite apparent stability may still require specialist evaluation or biopsy.

When to See a Pulmonologist

A pulmonologist specializes in diseases of the lungs and respiratory system. Referral is commonly appropriate when a pulmonary mass is discovered, especially when the diagnosis remains uncertain.

A pulmonologist may help:

• Review imaging
• Assess cancer risk
• Evaluate symptoms
• Arrange PET/CT
• Perform bronchoscopy
• Coordinate EBUS
• Arrange biopsy
• Evaluate infections or inflammatory disease
• Refer to thoracic surgery or oncology

Patients with suspicious lung masses are sometimes evaluated through multidisciplinary pulmonary nodule or lung cancer programs. These programs may include pulmonologists, radiologists, thoracic surgeons, oncologists, radiation oncologists, and pathologists.

Note: A coordinated approach can be especially useful when decisions about biopsy method, staging, and treatment need to be made together.

Questions to Ask Your Healthcare Provider

Receiving a report that mentions a lung mass can be stressful, and it may be difficult to know what information is most important.

Useful questions include:

• How large is the mass?
• Where in the lung is it located?
• What does it look like on CT?
• Are the borders smooth or irregular?
• Is there cavitation or calcification?
• Are any lymph nodes enlarged?
• Was the mass visible on an older scan?
• Has it grown?
• What are the most likely causes?
• How concerned are you about cancer?
• Do I need a PET/CT scan?
• Do I need a biopsy?
• Which biopsy technique is most appropriate?
• Should I see a pulmonologist?
• Should I see a thoracic surgeon?
• If cancer is diagnosed, what additional testing will be needed?
• Who will arrange the next test?
• When should the next step occur?

Note: Patients should make sure they leave the appointment with a clear plan. If additional testing is recommended, it is useful to know who is ordering it and when the results will be reviewed.

When to Seek Prompt Medical Attention

A lung mass itself does not necessarily create an emergency. However, certain symptoms may indicate significant bleeding, severe infection, airway obstruction, a collapsed lung, a blood clot, or another serious condition.

Seek urgent medical evaluation for symptoms such as:

• Coughing up a significant amount of blood
• Severe or rapidly worsening shortness of breath
• Sudden severe chest pain
• Blue or gray lips
• Fainting
• Confusion
• Severe weakness
• High fever with difficulty breathing
• Rapid deterioration in respiratory symptoms

Note: Other symptoms may not require emergency care but should still be evaluated. These include a persistent cough, repeated pneumonia, unexplained weight loss, persistent hoarseness, ongoing chest discomfort, or worsening shortness of breath.

Risk Factors for Lung Cancer

Because lung cancer is an important cause of pulmonary masses, clinicians review risk factors carefully.

Cigarette Smoking

Cigarette smoking is the most important preventable risk factor for lung cancer. Both current and previous smoking are relevant.

Risk generally increases with total lifetime exposure, which is often expressed in pack-years. One pack-year is equivalent to smoking an average of one pack of cigarettes per day for one year.

Stopping smoking reduces the risk over time, although former smokers may remain at elevated risk for many years.

Radon

Radon is a radioactive gas that forms naturally in soil and can accumulate inside buildings. Long-term radon exposure increases lung cancer risk.

Because radon cannot be seen or smelled, testing is necessary to determine whether levels inside a home are elevated.

Occupational Exposure

Certain workplace substances can increase the risk of lung cancer.

Examples include:

• Asbestos
• Silica
• Arsenic
• Chromium
• Nickel compounds
• Diesel exhaust
• Certain other industrial carcinogens

Note: A detailed occupational history may therefore be important when a suspicious lung lesion is being evaluated.

Personal and Family History

A person who previously had lung cancer has an increased risk of developing another lung cancer. A previous history of another type of cancer may also influence how a new lung mass is evaluated because the lesion could represent metastatic disease. A family history of lung cancer can also contribute to risk.

Chronic Lung Disease

Certain chronic lung conditions are associated with increased lung cancer risk, including COPD and pulmonary fibrosis. The relationship is influenced by multiple factors, including smoking exposure and chronic changes within the lung.

Can Lung Masses Be Prevented?

Not every lung mass can be prevented because the possible causes are so diverse. However, several measures can reduce the risk of lung cancer and certain lung diseases.

Stop Smoking

People who currently smoke can substantially improve their long-term health by quitting.

Options that may help include nicotine replacement therapy, prescription medications, behavioral counseling, quitlines, and structured smoking cessation programs.

Reduce Radon Exposure

Home radon testing can identify elevated levels. Professional mitigation systems can reduce radon concentrations when necessary.

Use Workplace Protection

People who work around asbestos, silica, dust, fumes, or other potentially harmful materials should follow recommended occupational safety procedures. Appropriate ventilation, respiratory protection, and exposure controls can reduce risk.

Complete Recommended Lung Cancer Screening

People at sufficiently high risk because of their age and smoking history may qualify for annual low-dose CT screening.

Screening is intended to detect lung cancer before symptoms develop and has been shown to reduce lung cancer mortality in appropriate high-risk populations.

Screening recommendations can change, so eligibility should be reviewed with a healthcare provider using current criteria.

Common Misunderstandings About Lung Masses

Every Lung Mass Is Cancer

A mass is not synonymous with cancer. Infections, inflammation, benign tumors, and other conditions can create mass-like abnormalities.

However, its size makes malignancy an important possibility that needs to be evaluated appropriately.

No Symptoms Means the Mass Is Benign

Some lung cancers cause no symptoms until they become relatively large or spread. Symptoms alone cannot distinguish between benign and malignant disease.

A Positive PET Scan Proves Cancer

PET activity can increase with cancer, infection, and inflammation. A positive PET scan raises or lowers probabilities but does not provide the same information as examining tissue under a microscope.

A Negative PET Scan Rules Out Cancer

Some cancers have relatively low metabolic activity. PET findings must be interpreted together with CT findings, clinical risk, and pathology when appropriate.

Antibiotics Can Determine Whether a Mass Is Cancer

A mass should not routinely be treated with antibiotics simply to see whether it disappears. Antibiotics are appropriate when clinical findings support bacterial infection.

When a suspicious lesion persists after appropriate treatment, further investigation may be necessary.

A Biopsy Always Gives a Definite Answer

Biopsies are extremely useful, but they can occasionally be nondiagnostic. The needle or bronchoscope may miss the abnormal tissue, or the sample may be too small to establish a diagnosis.

A suspicious mass may therefore require repeat biopsy, a different biopsy technique, or surgical removal even after an inconclusive result.

A Benign Biopsy Means No Follow-Up Is Ever Needed

A benign result is reassuring, but clinicians must determine whether the biopsy adequately sampled the lesion and whether the pathology result matches the imaging appearance.

If a very suspicious mass produces a small nonspecific tissue sample, additional evaluation may still be appropriate.

Coping With the Discovery of a Lung Mass

Waiting for additional imaging or biopsy results can create considerable anxiety. The word “mass” often causes people to assume that cancer has already been diagnosed, but that is not what the term means.

A useful first step is understanding exactly what the imaging report says. Ask about the size, location, appearance, comparison with previous studies, and recommended next step.

Obtaining prior imaging can sometimes provide important answers very quickly. A mass that is new carries a different implication from one that has remained unchanged for many years.

It can also be helpful to write down upcoming appointments and keep copies of imaging reports, biopsy results, and specialist recommendations.

Avoid relying on isolated phrases from a radiology report without discussing them with the healthcare professional managing the case. Terms such as “suspicious,” “spiculated,” or “PET avid” describe important findings but do not independently establish a cancer diagnosis.

Note: The goal is to move from an imaging finding to a clear diagnosis using the safest and most appropriate testing strategy.

Final Thoughts

A lung mass is an abnormal area in the lung larger than 3 centimeters, and its discovery deserves careful evaluation because malignancy is an important possibility. However, a mass is not automatically lung cancer. Infections, inflammation, benign tumors, scar tissue, and other conditions can sometimes look similar on imaging.

CT characteristics, previous scans, personal risk factors, PET/CT findings, and biopsy results may all contribute to the diagnosis. If a lung mass has been found, review the report with your healthcare provider, locate previous imaging when possible, and make sure you understand exactly what testing or specialist follow-up should happen next.